Bacterial and Fungal Clinical Trials

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Bacterial and Fungal Diseases

Top of Directory » All Categories » by Illness » Bacterial and Fungal Diseases



  • Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

    Conditions:   Tuberculosis;   HIV Infections
    Interventions:   Biological: AERAS-402;   Biological: Placebo Control
    Sponsors:   Aeras Global Tuberculosis Vaccine Foundation;   Crucell Holland BV
    Not yet recruiting - verified November 2009
  • Appropriate Timing of HAART in Co-infected HIV/TB Patients

    Conditions:   HIV Infections;   Tuberculosis
    Intervention:   Drug: tenofovir, lamivudine, efavirenz
    Sponsors:   Bamrasnaradura Infectious Diseases Institute;   Mahidol University;   Thai Red Cross AIDS Research Centre
    Recruiting - verified November 2009
  • TMC207-TiDP13-C112 - A Study to Investigate Pharmacokinetics, Safety and Tolerability of TMC207 in Patients With Moderately Impaired Hepatic Function

    Conditions:   Tuberculosis;   Liver Diseases
    Intervention:   Drug: TMC207
    Sponsor:   Tibotec-Virco Virology BVBA
    Not yet recruiting - verified November 2009
  • Human Anaplasmosis in Eastern France

    Conditions:   Anaplasmosis;   Tick-Borne Disease;   Ehrlichia
    Intervention:   Procedure: Blood sampling
    Sponsor:   University Hospital, Strasbourg, France
    Not yet recruiting - verified November 2009
  • Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial

    Condition:   Staphylococcus Aureus
    Interventions:   Biological: Monovalent rAT;   Biological: Monovalent rLukS-PV;   Biological: Bivalent rLukS-PV / rAT;   Biological: Placebo with adjuvant;   Biological: Placebo
    Sponsors:   Uniformed Services University of the Health Sciences;   Nabi Biopharmaceuticals
    Recruiting - verified November 2009
  • Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay

    Condition:   Latent Tuberculosis Infection
    Intervention:  
    Sponsor:   Samsung Medical Center
    Recruiting - verified November 2009
  • Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients

    Conditions:   Leprosy;   Disability Evaluation;   Quality of Life
    Intervention:   Other: exercise and orientation
    Sponsors:   University of Sao Paulo;   The National Council for Scientific and Technological Development (CNPq)
    Completed - verified November 2009
  • A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™

    Conditions:   Rotavirus Gastroenteritis;   Diphtheria;   Tetanus;   Pertussis
    Interventions:   Biological: Rotavirus Vaccine, Live, Oral, Pentavalent;   Biological: Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP);   Biological: Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)
    Sponsor:   Merck
    Not yet recruiting - verified October 2009
  • A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit Vaccine

    Condition:   Tuberculosis
    Interventions:   Biological: 50 microgram antigen (Ag85B + ESAT-6);   Biological: 50 microgram antigen (Ag85B + ESAT-6) + 100 nmol KLK + 4 nmol ODN1a;   Biological: 50 microgram antigen (Ag85B + ESAT-6) + 500 nmol KLK + 20 nmol ODN1a
    Sponsors:   Statens Serum Institut;   TBVac
    Completed - verified October 2009
  • A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months

    Condition:   Meningococcal Disease
    Intervention:   Biological: MenACWY conjugate vaccine plus routine infant vaccines
    Sponsors:   Novartis;   Novartis Vaccines
    Not yet recruiting - verified October 2009
  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials